Oppenheimer analyst Matthew Biegler says Blueprint Medicines (BPMC) reported Q4 Ayvakit sales of $146M, in line with consensus but below the ...
Welcome to the latest edition of “Quantum Leap” where The Fly decodes news and activity in the quantum computing space. Maximize Your Portfolio ...